Anaphylactic reaction and Quincke's disease

Summary:

Quincke's disease is found among people with Anaphylactic reaction, especially for people who are female, 30-39 old.

The study analyzes which people have Quincke's disease with Anaphylactic reaction. It is created by eHealthMe based on reports of 60 people who have Anaphylactic reaction from the Food and Drug Administration (FDA), and is updated regularly. You can use the study as a second opinion to make health care decisions.

Phase IV trials are used to detect adverse drug outcomes and monitor drug effectiveness in the real world. With medical big data and AI algorithms, eHealthMe is running millions of phase IV trials and makes the results available to the public. Our original studies have been referenced on 600+ medical publications including The Lancet, Mayo Clinic Proceedings, and Nature.

On Feb, 07, 2023

60 people who have Anaphylactic Reaction and Quincke'S Disease are studied.

What is Anaphylactic reaction?

Anaphylactic reaction (serious allergic reaction) is found to be associated with 3,086 drugs and 2,612 conditions by eHealthMe.

What is Quincke's disease?

Quincke's disease (a form of localized swelling of the deeper layers of the skin and fatty tissues beneath the skin) is found to be associated with 949 drugs and 468 conditions by eHealthMe.

Number of Quincke's disease in Anaphylactic reaction reports submitted per year:

Would you have Quincke's disease when you have Anaphylactic reaction?

Gender of people who have Anaphylactic Reaction and experienced Quincke'S Disease *:

female: 91.53 %
male: 8.47 %

Age of people who have Anaphylactic Reaction and experienced Quincke'S Disease *:

Common co-existing conditions for these people *:

Skin Blushing/flushing (a sudden reddening of the face, neck): 4 people, 6.67%
Immune System Disorder: 4 people, 6.67%
Complement Factor Abnormal: 3 people, 5.00%
Enzyme Abnormality: 2 people, 3.33%
Gastroesophageal Reflux Disease (a condition in which stomach contents leak backward from the stomach into the oesophagus): 2 people, 3.33%
Swallowing Difficulty: 1 person, 1.67%
Blood Glucose Decreased: 1 person, 1.67%
Breakthrough Pain: 1 person, 1.67%
Bronchitis Chronic (inflammation of the mucous membrane in the bronchial tubes- chronic): 1 person, 1.67%
Cellulitis (infection under the skin): 1 person, 1.67%

Common drugs taken by these people *:

Common symptoms for these people *:

Laryngeal Oedema (swelling of larynx): 9 people, 15.00%
Pneumonia: 4 people, 6.67%
Drug Ineffective: 4 people, 6.67%
Infusion Related Reaction: 4 people, 6.67%
Throat Tightness: 3 people, 5.00%
Malaise (a feeling of general discomfort or uneasiness): 3 people, 5.00%
Respiratory Tract Oedema (swelling of respiratory tract due to excess fluid collection in tissue): 3 people, 5.00%
Pharyngeal Oedema (abnormal accumulation of fluid in the cavities and intercellular spaces of the pharyngeal): 3 people, 5.00%
Hoarseness Or Changing Voice: 3 people, 5.00%
Infection: 2 people, 3.33%

* Approximation only. Some reports may have incomplete information.

Do you take medications and have Quincke's disease?

Check whether Quincke's disease is associated with a drug or a condition

How to use the study?

You can discuss the study with your doctor, to ensure that all drug risks and benefits are fully discussed and understood.

Related publications that referenced our studies

Krishnan K, Krishnasamy K, "Evaluation of anaphylactic reaction as an adverse event for perindopril erbumine tablets", International Current Pharmaceutical Journal, 2014 Mar .
Wang JH, King TM, Chang MC, Hsu CW, "Oxaliplatin-induced severe anaphylactic reactions in metastatic colorectal cancer: case series analysis", World journal of gastroenterology: WJG, 2012 Oct .

Related studies

Treatments, associated drugs and conditions:

Anaphylactic reaction (78,713 reports)
Quincke's disease (16,202 reports)

COVID vaccines that are related to Quincke's disease:

Common drugs associated with Quincke's disease:

How the study uses the data?

The study is based on Quincke's disease and Anaphylactic reaction, and their synonyms.

Who is eHealthMe?

With medical big data and proven AI algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 600+ medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.